Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lieberman

Showing results (101-110 of 209) with videos related to

Pageof 21
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|June 29, 2022
Cost-Effectiveness of Waiving Coinsurance for Follow-Up Colonoscopy after a Positive Stool-Based Colorectal Screening Test in a Medicare PopulationA Mark Fendrick, David Lieberman, Vahab Vahdat, et al.
The Journal of the American Board of Family Practice|March 12, 2004
Clinical and laboratory profile of febrile respiratory infections in general practicePesach Shvartzman, David Lieberman, Howard Tandeter, et al.
Cancer Cytopathology|December 20, 2015
Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experienceShuanzeng Wei, David Lieberman, Jennifer J D Morrissette, et al.
Gastroenterology|March 29, 2024
Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or ColonoscopyUri Ladabaum, Ajitha Mannalithara, Yingjie Weng, et al.
Cancer Research Communications|October 3, 2023
Impact of Eliminating Cost-Sharing by Medicare Beneficiaries for Follow-Up Colonoscopy After a Positive Stool-based Colorectal Cancer Screening TestA Mark Fendrick, David Lieberman, Jing Voon Chen, et al.
Journal of Clinical Microbiology|February 4, 2006
Nasopharyngeal versus oropharyngeal sampling for isolation of potential respiratory pathogens in adultsDavid Lieberman, Elena Shleyfer, Hana Castel, et al.
Archives of Pathology & Laboratory Medicine|June 19, 2019
Validation of a Next-Generation Sequencing Assay Targeting RNA for the Multiplexed Detection of Fusion Transcripts and Oncogenic IsoformsRobyn T Sussman, Amanda R Oran, Carmela Paolillo, et al.
Diagnostic Microbiology and Infectious Disease|February 16, 2007
Naso- and oropharyngeal potential respiratory pathogens in adults with nonpneumonic lower respiratory tract infectionDavid Lieberman, Avi Shimoni, Elena Shleyfer, et al.
Biomedical Chromatography : BMC|June 3, 2015
Volatile organic compounds generated by cultures of bacteria and viruses associated with respiratory infectionsAmir Abd El Qader, David Lieberman, Yonat Shemer Avni, et al.
Journal of Medical Economics|April 27, 2021
Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare populationDeborah A Fisher, Jordan J Karlitz, Sushanth Jeyakumar, et al.
Pageof 21

Showing results (101-110 of 209) with videos related to

Sort By:
Pageof 21
Cancer Prevention Research (Philadelphia, Pa.)|June 29, 2022
Cost-Effectiveness of Waiving Coinsurance for Follow-Up Colonoscopy after a Positive Stool-Based Colorectal Screening Test in a Medicare PopulationA Mark Fendrick, David Lieberman, Vahab Vahdat, et al.
The Journal of the American Board of Family Practice|March 12, 2004
Clinical and laboratory profile of febrile respiratory infections in general practicePesach Shvartzman, David Lieberman, Howard Tandeter, et al.
Cancer Cytopathology|December 20, 2015
Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experienceShuanzeng Wei, David Lieberman, Jennifer J D Morrissette, et al.
Gastroenterology|March 29, 2024
Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or ColonoscopyUri Ladabaum, Ajitha Mannalithara, Yingjie Weng, et al.
Cancer Research Communications|October 3, 2023
Impact of Eliminating Cost-Sharing by Medicare Beneficiaries for Follow-Up Colonoscopy After a Positive Stool-based Colorectal Cancer Screening TestA Mark Fendrick, David Lieberman, Jing Voon Chen, et al.
Journal of Clinical Microbiology|February 4, 2006
Nasopharyngeal versus oropharyngeal sampling for isolation of potential respiratory pathogens in adultsDavid Lieberman, Elena Shleyfer, Hana Castel, et al.
Archives of Pathology & Laboratory Medicine|June 19, 2019
Validation of a Next-Generation Sequencing Assay Targeting RNA for the Multiplexed Detection of Fusion Transcripts and Oncogenic IsoformsRobyn T Sussman, Amanda R Oran, Carmela Paolillo, et al.
Diagnostic Microbiology and Infectious Disease|February 16, 2007
Naso- and oropharyngeal potential respiratory pathogens in adults with nonpneumonic lower respiratory tract infectionDavid Lieberman, Avi Shimoni, Elena Shleyfer, et al.
Biomedical Chromatography : BMC|June 3, 2015
Volatile organic compounds generated by cultures of bacteria and viruses associated with respiratory infectionsAmir Abd El Qader, David Lieberman, Yonat Shemer Avni, et al.
Journal of Medical Economics|April 27, 2021
Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare populationDeborah A Fisher, Jordan J Karlitz, Sushanth Jeyakumar, et al.
Pageof 21